About
Depression Diagnostics
Areas of Focus
Categories
DiagnosticsMiddle East
Team (17)
Alexander Harris, MD, PhD
Associate Professor
NeuroKaire
team_member
Barbara Corneo, PhD
Associate Professor
NeuroKaire
team_member
Daphna Laifenfeld, PhD
Member
NeuroKaire
team_member
David Pattison, CPA
VP of Business Development
NeuroKaire
executive
Elad Bibi Aviv
COO
NeuroKaire
executive
Gosia Jaremko, PhD, MBA
Chief Laboratory Officer
NeuroKaire
team_member
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
294
By Phase
PHASE3: 1PHASE4: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05331937Collaborator
TMS for Exposure Therapy Resistant OCD
PHASE3Recruiting
250 participants
Started: May 16, 2022 · Completed: Sep 1, 2027
NCT00200941Lead Sponsor
Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome
PHASE4Completed
44 participants
Started: Aug 31, 2001 · Completed: Apr 30, 2005
Locations (1)
Headquarters
Tel Aviv, Israel
Map
Loading map...